Infusion of TGF-β-primed CD4+CD25+ cells significantly suppressed the Th1 frequency in lupus mice whereas treatment with atRA/TGF-β-primed CD4+CD25+ cells resulted in the most significant suppression against Th1 cell production in lupus mice (Figure 2E). The gene discussed is CD4; the disease is systemic lupus erythematosus.